[1] HARMAN G，LIMBIRD L E，MORINOFF P B，et al. Goodman and Gilman’s the pharmacological basis of therapeutics. 9th ed. New York：McGaw-Hill，1996.

[2] MCQUAY H，CARROLL D，JADAD A，et al. Anticonvulsant drugs for management of pain：a systemic review. Br Med J，1995，311：1047-1052.

[3] TREMONT-LUKATS I W，MEGEFF C，BACKONJA M M. Anticonvulsants for neuropathic pain syndromes，mechanism of action and place in therapy. Drugs，2000，60：1029-1062.

[4] DWORKIN R H，BACKONJA M. ROWBOTHAM M C，et al. Advances in neuropathic pain：diagnosis，mechanisms and treatment recommendations. Arch Neruol，2003，60：1524-1534.

[5] PAPPAGALLO M. Newer antiepileptic drugs：possible uses in the treatment of neuropathic pain and migraine. Clinical Therapeutics，2003，25：2506-2538.

[6] SOTAH M. FOONG F W. A mechanism of carbamazepine analgesia as shown by bradykinin-induced trigemeinal pain. Brain Res Bull，1983，10：407-409.

[7] BLOM S. Trigeminal neuralgia：its treatment with a new anticonsulsant drug. Lancet，1962，1：839-840.

[8] CAMPBELL F G，GRAHAM J G，ZILKHA K J. Clinical trial of carbamazepine（Tegretaol）in trigeminal neuralgia. J Neurol Neurosrug Psychiatry，1966，26：265-267.

[9] ROCKLIFF B W，DAVIS E H. Controlled sequential trials of carbamazepine in trigeminal neuralgia. Arch Neurol，1966，15：129-136.

[10] NICOL C. A four-year double-blind，randomized study of Tegretol in facial pain. Headache，1969，9：54-57.

[11] WILTON T. Tegretol in the treatment of diabetic neuropathy. South Afr Med J，1974，27：869-872.

[12] LINDSTROM P，LINDSTROM U. The analgesic effect of tocainide in trigeminal neuralgia. Pain，1987，28：45-50.

[13] VILMING S T，LYBERG T，LATASTE X. Tizanidine in the management of trigeminal neuralgia. Cephalagia，1986，6：181-182.

[14] LECHIN F，VAN D D B，LECHIN M E，et al. Pimozide therapy for trigeminal neuralgia. Arch Neurol，1989，46：960-963.

[15] RULL J A，QUIBRERA R，GONZALES-MILLAN H，et al. Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine：double-blind crossover study. Diabetologia，1969，5：215-220.

[16] GOMEZ-PEREZ F J，CHOZA R，RIOS J M，et al. Nortriptyline-fluphenazine vs carbamazepine in the symptomatic treatment of diabetic neuropathy. Arch Med Res，1996，27：525-529.

[17] GERSON G R. Studies on the concomitant use of carbamazepine and clomipramine for the relief of postherpetic neuralgia. Postgrad Med J，1977，53（S4）：104-109.

[18] LEIJON G，BOIVIE J. Central post-stroke pain- a controlled trial of amitriptyline and carbamazepine. Pain，1989，36：27-36.

[19] FARAGO F. Trigeminal neuralgia：its treatment with two new carbamazepine analogues. Eur Neurol，1987，26：73-83.

[20] ZAKRZEWSKA J M，PATSALOS P N. Oxcarbazepine，a new drug in the management of intractable trigeminal neuralgia. J Neurosurg Neurol Psychiatry，1989，52：472-476.

[21] REMILLARD G. Oxcarbazepine and intractable trigeminal neuralgia. Epilepsia，1994，35：S28-S29.

[22] LINDSTROM P. The analgesic effect of carbamazepine in trigeminal neuralgia. Pain，1987，4：S85.

[23] MCCLEAN N J，SCHMUTZ M，WAMIL A W，et al. Oxcarazepine：mechanism of action. Epilepsia，1994，35：55.

[24] BEYDOUN A，SCHMIDT D，D’SOUZA J. Meta-analysis of comparative trials of oxcarbazepine versus carbamazepine in trigeminal neuralgia. J Pain，2002，3：749.

[25] BEYDOUN A，KOBERTZ S A，CARRAZANA E J. Efficacy of oxcarbazepine in the treatment of painful diabetic neuropathy. Clin J Pain，2004，20：174-178.

[26] DOGRA S，BEYDOUN A，MAZZOLA J，et al. Oxcarbazepine in painful diabetic neuropathy：A randomized，placebo-controlled study. Eur J Pain，2005，9：543-554.

[27] ROYAL M A，JENSON M，BHAKTA B，et al. An open-label trial of oxcarbazepine in patients with complex regional pain syndrome refractory to gabapentin. J Pain，2002，3：763.

[28] WARD S，ROYAL M，JENSON M，et al. An open-label trial of oxcarbzepine in patients with radiculopathy refractory to gabapentin. J Pain，2002，3：765.

[29] JENKINS K，KAPLAN S E，LEAHY L F，et al. Oxcarbazepine in central neuropathic pain with allodynia following spinal cord injury. J Pain，2002，3：10.

[30] MAGENTA P，ARGHETTI S，DI PALMA F，et al. Oxcarbazepine is effective and safe in the treatement of neuropathic pain：pooled analysis of seven clinical studies. Neurological Science，2005，26：218-226.

[31] CRISCUOLO S，AULETTA C，LIPPI S，et al. Oxcarbazepine monotherapy in postherpetic neuralgia unresponsive to carbamazepine and gabapentin. Acta Neurol Scand，2005，111：229-232.

[32] BERGOUIGANAN M. Cures heureuses de nevralgies faciales essentielles par diphenyl-hidantoinate de soude. Rev Laryngol Otol Rhinol，1942，63：34-41.

[33] SWERDLOW M. Anticonvulsant drugs and chronic pain. Clin Neuropharmacol，1984，7：51-82.

[34] SAUDEK C D，WERNS S，REIDENBERG M M. Phenytoin in the treatment of diabetic symmetrical polyneuropathy. Clin Pharmacol Ther，1977，22：196-199.

[35] CHADDA V S，MATHUR M S. Double blind study of the effects of diphenylhidantoin sodium in diabetic neuropathy. J Assoc Phy India，1978，26：403-406.

[36] YAJNIK S，SINGH G P，SINGH G，et al. Phenytoin as a aoanalgesic in cancer pain. J Pain Symptom Manage，1992，7：209-213.

[37] MCCLEANE G J. Intravenous infusion of phenytoin relieves neuropathic pain：a randomized，doubleblinded，placebo-controllled，crossover study. Anesth Analg，1999，89：985-988.

[38] WEBB J，KAMALI F. Analgesic effects of lamotrigine and phenytoin on cold-induced pain：a crossover placebo-controlled study in healthy volunteers. Pain，1998，76：357-363.

[39] GEE N S，BROWN J P，DISSANAYAKE V U，et al. The novel anticonvulsant drug，gabapentin（Neurontin）binds to the alpha-s-delta subunit of the calcium channel. J Bio Chem，1996，271：5768-5776.

[40] ROSE M A，KAM P C. Gabapentin：pharmacology and its use in pain management. Anaesthesia，2002，587：451-462.

[41] MELLICK G A，MELLICK L B. Gabapentin in the management of reflex sympathetic dystrophy. J Pain Symptom Manage，1995，10：265-266.

[42] KHAN O. Gabapentin relieves trigeminal neuralgia in multiple sclerosis patients. Neurology，1998，51：611-614.

[43] ROSNER H，RUBIN L，KESTENBAUM A. Gabapentin adjunctive therpy in neuropathic pain states. Clin J Pain，1996，12：56-58.

[44] SIST T C，FILADORA V A，MINER M，et al. Experience with gabapentin for neuropathic pin in the head and neck：report of ten cases. Reg Anesth，1997，22：473-478.

[45] MERRAN M. Gabapentin for treatment of pain and tremor. South Med J，1998，91：739-744.

[46] CARACENI A，ZECCA E，MARTINI C，et al. Gabapentin as an adjuncit to opioid analgesi for neuropathic cancer pain. J Pain Symptom Manage，1999，17：441-445.

[47] ROWBOTHOM M，HARDEN N，STACEY B，et al. Gabapentin for the treatment of post-herpetic neuralgia：A randomized controlled trial. JAMA，1998，280：1837-1842.

[48] RICE A S，MATON S. Gabapentin in post herpetic neuralgia：A randomized double blind，plaxebo controlled study. Pain，2001，94：215-224.

[49] BACKONJA M，BEYDOUN A，EDWARDS K R，et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus：randomized controlled trial. JAMA，1998，280：1831-1836.

[50] MORELLO C M，LECKBAND S G，STONER C P，et al. Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy. Arch Intern Med，1999，159：1931-1937.

[51] Serpell MG and the Neuropathic Pain Study Group. Gabepntin in neuropathic pain syndromes：A randomized，double blind，placebo-controlled trial. Pain，2002，99：557-566.

[52] LEVENDOGLU F，OGUN C O，OZERBIL O，et al. Gabepntin is a first line drug for the treatment of neuropatic pain in spinal cord injury. Spine，2004，29：743-751.

[53] HAHN K，ARENDT G，BRAUN J S，et al. A placebo-controlled trial of gabapentin or painful HIV-associated sensory neuropathies. J Neurol，2004，251：1260-1266.

[54] BENNETT M I. Gabapentin significantly improves analgesia in people receving opiods for neuropathic cancer pain. Cancer Treatement Reviews，2005，31：58-62.

[55] FASSOULAKI A，PATRIS K，SARANTOPOULOS C，et al. The analgesic effect of gabapentin and mexilitene after breast surgert for cancer. Anesth Analg，2002，95：985-991.

[56] PANDEY C K，PRIYE S. SINGH S，et al. Preemptive uses of gabapentin significantly decrease postoperative pain and rescue nalgesic requirements in laporoscopic cholecystectomy. Can J Anaesth，2004，51：358-363.

[57] TURAN A，KARARMANLIOGLU B，MEMIS D，et al. The analgesic effects of gabapentin after total abdominal hysterectomy. Anesth Anagl，2004，98：1370-1373.

[58] ROSARIUS M G，MENNANDER S，SUOMINEN P，et al. Gabapentin for the prevention of postoperative pain after vaginal hysterectomy. Pain，2004，110：175-181.

[59] GILRON I，ORR E，TU D，et al. A placebo-controlled randomized clinical trial of perioperative administration of gabapentin，rofecoxib and their combination for spontaneous and movement-evoked pain after abdominal hysterectomy. Pain，2005，113：191-200.

[60] GAO B，SEKIDO Y，MAXIMOV A，et al. Functional properties of a new voltage-dependent calcium channel alpha（2）delta auxiliary subunit gene（CACNA2D2）．J Biol Chem，2000，275：12237-12242.

[61] FINK K，DOOLEY D J，MEDER W P，et al. Inhibition of neuronal Ca ²⁺ influx by gabapentin and pregabalin in the human neocortex. Neuropharmacology，2002，42：229-236.

[62] BUSCH J，STRAND J A，POSVAR E L，et al. Pregabalin single-dose pharmacokinetics and safe/tolerance in healthy subjects after oral administration of pregabalin solution or capsule doses. Epilepsia，1998，39（S6）：58.

[63] LESSER H，SHARMA U，LAMOREAUX L，et al. Pregabablin relieves symptoms of painful diabetic neuropathy. A randomized controlled trial. Neurology，2004，63：2104-2110.

[64] RICHTER R W，PORTENOY R，SHARMA U，et al. Relief of painful diabetic peripheral neuropathy with pregabalin：a randomized，placebo-controlled trial. J Pain，2005，6：253-260.

[65] DWORKIN R H，CORBIN A E，YOUNG J P，et al. Pregabalin for the treatment of postherpetic neuralgia.a randomized，placebo-controlled trial. Neurology，2003，60：1274-1283.

[66] SABATOWSKI R，GALVEZ R，CHERRY D A，et al. Pregabalin reduces pain and improves sleep and mood disturbance with post-herpetic neuralgia：results of a randomized，placebo-controlled clinical trial.Pain，2004，109：26-35.

[67] ROSENSTOCK J，TUCHMAN M，LAMOREAUX L，et al. Pregablin for the treatment of painful diabetic peripheral neuropathy：a double-blind，placebo-controlled trial. Pain，2004，110：628-638.

[68] FREYNHAGEN R，STROJEK K，GRIESING T，et al. Efficacy of pregabalin in neuroapthic pain evaluated in a 12 week，randomized，double-blind，multicentre，placebo-controlled trial of flexible- and fixed-dose regimens. Pain，2005，115：254-263.

[69] HILLL C M，BALKENOHL M，THOMAS D W，et al. Pregabalain in patients with postoperative dental pain. Eur J Pain，2001，5：119-124.

[70] LEACH M J，MARDEN C M，MILLER A A. Pharmacological studies on lamotrigine，a noval potential antiepileptic drug. Ⅱ neurochemical studies on the mechanism of action. Epilepsia，1986，27：490-497.

[71] LEES G，LEACH M J. Studies on the mechanism of action of the novel anticonvulsant lamotrigine（Lamictal）using primary neuroglial cultures from rat cortex. Brain Res，1993，612：190-199.

[72] TEOH H，FOWLER U，BOWERY N G. Effect of lamotrigine on the electrically-evoked release of endogenous amino acids from slices of dorsal horn of the rat spinal cord. Neuropharmacology，1995，34：1273-1278.

[73] LUNARDI G，LEANDRI M，ALBANO C，et al. Clinical effectiveness of lamotrigine and plasma levels in essential and symptomatic trigeminal neuralgia. Neurology，1997，48：1714-1717.

[74] SOLARO C，MESSMER U M. UCCELLI A，et al. Low-dose gabapentin combined with either lamotrigine or carbamazepine can be useful therapies for trigeminal neuralgia in multiple sclerosis. Eurpean Neurology，2000，44：45-48.

[75] LEANDRI M，LUNARDI G，INGLESE M，et al. Lamotrigine in trigeminal neuralgia secondary to multiple sclerosis. J Neurol，2000，247：556-558.

[76] MCCLEANE G. Lamotrigine can reduce neurogenic pain associated with multiple sclerosis. Clin J Pain，1998，14：269-270.

[77] CIANCHETTI C，ZUDDAS A，RANDAZZO A P. Lamotirigine adjunctive therapy in painful phenomena in MS：preliminary obwervations. Neurology，1999，53：433.

[78] ZAKRZEWSKA J M，CHAUDHRY Z，NURMIKKO T J，et al. Lamotrigine（Lamictal）in refractory trigeminal neuralgia：results from a double-blind placebo-controlled cross-over trial. Pain，1997，73：223-230.

[79] SIMPSON D M，MCAUTHUR J C，OLNEY R，et al. Lamotrigine for HIV-associated painful sensory neuropathy. a placebo-controlled trial. Neurology，2003，60：1508-1514.

[80] EISENBERG E，LURIE Y，BRAKER C，et al. Lamotirgine reduces painful diabetic neuropathy：a randomized，controlled study. Neurology，2001，57：505-509.

[81] VESTERGAARD K，ANDERSEN G，GOTTRUP H，et al. Lamotrigine for central poststroke pain. A randomized controlled trial. Neurology，2001，54：184-190.

[82] FINNERUP N B，SINDRUP S H，BACH F W，et al. Lamotrigine in spinal cord injury pain：a randomized controlled trial. Pain，2002，96：375-383.

[83] MCCLEANE G. 200 mg daily of lamotrigine has no analgesic effect in neuropathic pain：a randomized，double-blind，placebo controlled trial. Pain，1999，83：105-107.

[84] DEVULDER J. Is 200 mg lamotrigine daily analgesic or not? Pain，2000，86：211.

[85] WHEELER S D. Lamotigine efficacy in migraine prevention. Cephalalgia，2001，21：A374.

[86] D ANDREA G，GRANELLA F，GHIOTTO N，et al. Lamotrigine in the treatment of SUNCT syndrome.Neurology，2001，57：1723-1725.

[87] EISENBERG E，DAMUNNI G，HOFFER E，et al. Lamotrigine for intractable sciatica：correlation between dose，plasma concentration and analgesia. Eur J Pain，2003，7：485-491.

[88] HARBISON J. DENNEHY F，KEATING D. Lamotrigine for pain with hyperalgesia. Irish Med J，1997，90：56.

[89] MCCLEANE G J. The symptoms of complex regional pain syndrome type I alleviated with lamotrigine. A report of 8 cases. J Pain，2000，1：171-173.

[90] BONICAIZI V，CANAVERO S，CERUTTI F，et al. Lamotrigine reduces total postoperative analgesic requirement：a randomized double-blind，pleacebo-controlled pilot study. Surgery，1997，122：567-570.

[91] STERKER M，BERROUSCHOT J，SCHNEIDNER D. Fatal course of toxic epidermal necrolysis under treatment with lamotrigine. Int J Clin Pharmacol Ther，1995，33：595-597.

[92] GLAUSER T A. Topiramate. Epilepsia，1999，40：S71-80.

[93] ROSENFIELD W E. Topiramate：a review of preclinical，pharmacokinetic，and clinical data. Clin Ther，1997，19：1294-1308.

[94] STOREY J R，POTTER D L，HART D E，et al. A double-blind，randomized，placebo-controlled，parallel study to determine the efficacy of topiramate in the prophylactic treatment of migraine. Neurology，2000，54：A267-A268.

[95] EDWARDS K R，GLANZ M J，SHEA P，et al. A double blind，randomized trial of topiramate versus placebo in the prophylactic treatment of migraine headache with and without aura. Cephalalgia，2000，20：516.

[96] EDWARDS K R，POTTER D L，WU S C，et al. Topiramate in the preventive treatment of epidosic migraine；a combined analysis from pilot，double-blind，placebo-controlled trials. CNS spectr，2003，8：428-432.

[97] MATTHEW N T，DODICK D W，SCHMITT J，et al. Topiramate in migraine prevention（MIGR-001）；Effect on migraine frequency. Neurology，2003，60：A336.

[98] BRANDES J L，JACOBS D，NETO W，et al. Topiramate in the prevention of migraine headache：A randomized，double-blind，placebo-controlled，parallel study（MIGR-002）．Neurology，2003，60：A238.

[99] EDWARD K R，GLANZ M J，BUTTON J，et al. Efficacy and safety of topiramate in the treatment of painful diabetic neuropathy：a double-blind，placebo-controlled study. Neurology，2000，54：A81.

[100] VINIK A，HEWITT D，XIANG J. Topiramate in the treatment of painful diabetic neuropathy：results from a multicenter，randomized，double-blind，placebo-controlled trial. Neurology，2003，60：A154-A155.

[101] ZVARTAU-HIND M，DIN M U，GILANI A，et al. Topiramate relieves refractory trigeminal neuralgia in MS patients. Neurology，2000，55：1587-1588.

[102] SOLARNO C，UCCELLI M M，BRICHETTO G，et al. Topiramate relieves idiopathic and symptomatic trigeminal neuralgia. J Pain Symptom Manage，2001，21：367-368.

[103] GILRON I，BOOHER S L，ROWAN J S，et al. Topiramate in trigeminal neuralgia：a randomized，placebocontrolled multiple crossover pilot study. Clin Neruopharmacol，2001，24：109-112.

[104] CANAVERO S，BONICALZI V，PAOLOTTI R. Lack of effect of topiramate for central pain. Neurology，2002，58：831-832.

[105] BAJWA Z H，SAMI N，WARFIELD C A，et al. Topiramae relieve refractory intercostal neuralgia. Neurology，1999，52：1917.

[106] D’ALEO G，SESSA E，DI BELLA P，et al. Topiramate modulates of R3 noiceptive reflex in multiple sclerosis patients suffering paroxysmal symptoms. J Neurol，2001，248：996-999.

[107] KHOROMI S，PATSALIDES A，PARADA S，et al. Topiramate in chronic lumber radicular pain. J Pain，2005，6：829-836.

[108] SATA S. Benzopiazepines，clonazepine. In Levy RH，Mattson RH，Meldrum BS. eds. Antiepileptic Drugs.4th ed. New York：Raven Press，1995，725-734.

[109] CACCIA M B. Clonazepine in facial neuralgia and cluster headache. Clinical and electrophysiological study. Eur Neuolo，1975，13：560-563.

[110] COURT J E，KASE C S. Treatment of tic douloureux with a new anticonvuslana（clonazepine）．J Neurol Neurosurger Psychiatr，1976，39：297-299.

[111] SMIRNE S，SCARLATO G. Clonazepine in cranial neuralgia. Med J Aust，1977，1：93-94.

[112] BOUKHOMS A J，LITMAN R E. Clonazepine in the treatment of neuralgia pain syndrome. Psychosomatics，1985，26：933-936.

[113] SWERDLOW M，CUNDILL J G. Anticonvuslant drugs in the treatment of lanceninating pain：a comparison. Anaesthesia，1981，36：1129-1132.

[114] ANON. Tiagbine for epilepsy. Med Lett Drugs Ther，1998，40：45.

[115] DCHTER M A，BRODIE M J. New epileptic drugs. N Engl J Med，1996，334：1583-1590.

[116] GUSTAVSON L E，SOELLNER S W，GRANNEMAN G R，et al. A single dose study to define tiagabine pharmacokinetics in partial seizures. Neurology，1997，48：1032-1037.

[117] NOVAK V，KANARD R，KESSEL J T，et al. Treatment of painful sensory neurpathy with tiagabine：a pilot study. Clin Auton Res，2001，11：357-361.

[118] JOHANNESSEN C U. Mechanism of action of valproate：a commentary. Neurochem Int，2000，37：103-110.

[119] PEIRIS J B，PERERA G L S，DVENDRA S V，et al. Sodium valproate in trigeminal neuralgia. Med J Aust，1980，2：278-279.

[120] RAFFERY H. The management of post herpetic pain using sodium valproate and amitriptyline. Irish Med J，1979，72：399-401.

[121] BOWSHER D，LAHUERTA J，NELSON A. A case of tabes dorsalis with tonic pupils and lightening pains relieved by sodium valproate. J Neurol Neurosurg Psychiatry，1987，50：239-241.

[122] DREWES A M，ANDREASSEN A，POULSEN L H. Valproate for treatment of chronic entral pain after spinal cord injury：a double-blind cross-over study. Paraplegia，1994，32：565-569.

[123] JENSEN R，BRINCK T，OLESEN J. Sodium valproate has a prophylatic effect in migraine without arua：a triple-blind，placebo-controlled crossover study. Neurology，1994，44：647-651.

[124] SILBERSTEIN S D. Divalproex sodium in headache：literature review and clinical guidelines. Headache，1996，36：547-555.

[125] ROTHROCK J F. Clinical studies of valproate for migraine prophylaxis. Cephalalqia，1997，17：81-83.

[126] NORTON J. Use of intravenous valproate sodium in status migraine. Headache，2000，40：755-757.

[127] GALLAGHER R M，MUELLER L L，FREITAG F G. Divalproex sodium in the treatment of migraine and cluster headache. J Am Ostopath Assoc，2002，102：92-94.

[128] HAMMOND E J，PERCHALSKI R J，WILDER B J. Neuropharmacology of zonisamide，a new antiepileptic drug. Gen Pharamcol，1987，28：303-307.

[129] MASUDA Y，ISHIZAKI M，SHIMIZU M. Zonisamide：pharmacology and clinical efficacy in epilepsy.CNS Drug Review，1996，4：341-360.

[130] LEPPIK I E. Zonisamide. Epilepsia，1999，40：S23-S29.

[131] BACKONJA M M. Use of anticonvulsants for treatment of neuropathic pain. Neurology，2002，59：S14-S17.

[132] KRUSZ J. Zonisamide as a treatment for chronic pain. Abstract book of the 22 ^nd Annual Meeting of the American Pain Society，2003，A938.

[133] KAPLAN M. Pain relief and wight loss in patients treated with zonisamide. Abstract book of the 22 ^nd Annual Meeting of the American Pain Society，2003，A944.

[134] NOYER M，GILLARD M，MATAGNE A，et al. the novel antiepileptic drug levetiracetam（ucb L059）appears to act via a specific binding site in CNS membrane. Eur J Pharmacol，1995，286：137-46.

[135] RIZZO M. Adjunctive levetiracetam therapy for myelopthic pain and paresthesia in MS. Abstract book of the 22 ^nd Annual Meeting of the American Pain Society，2003，A911.

[136] DUNTEMAN E. Leveiracetam adjunctive analgesia in neoplastic plexopathies. Abstract book of the 22 ^nd Annual Meeting of the American Pain Society，2003，A942.

[137] COCHRAN J. Levetriacetam（Keppra）in neuropathic pain：a pilot study. Abstract book of the 22 ^nd Annual Meeting of the American Pain Society，2003，A95.

[138] PATERSON S，STEWART S. levetiracetam is effective in the treatment of chronic pain：A prospective open label case series. Abstract Book of the 22 ^nd Annual Meeting of the American Pain Society，2003，A949.

[139] EMPTING L，HUGHLEY Q，MILLIKEN M. Levetiracetam in the treatment of traumatically induced sympathetic independent neuropathic pain and post-operative radiculopathy. Abstract book of the 22 ^nd Annual Meeting of the American Pain Society，2003，A932.

[140] PRICE M J. Levetiracetam in the treatment of neuropathic pain：Three case studies. Clin J Pain，2004，20：33-36.

[141]谭刚，郭向阳，罗爱伦．神经病理性疼痛药物治疗的现状．中华外科学杂志，2005，43：474-476.

[142]吕美红，安刚．慢性疼痛处理指南．临床麻醉学杂志，2005，21：359-360.

[143]何睿林，谭宪湖，蒋宗滨．口服加巴喷丁治疗带状疱疹后神经痛的临床观察．医学文选，2005，24：663-665.

[144]朱凌兰，姜晓钟，赵云富．钠通道阻断剂用于治疗慢性疼痛的进展．上海医学，2004，27：442-444.

[145]钱滔来，高崇荣．神经性疼痛的治疗现状及进展．中国疼痛医学杂志，2004，21：305-307.

[146]高崇荣．慢性疼痛治疗的现状与展望．现代医院，2004，4：22-25.

[147]宋文阁，傅志俭，谢田．带状疱疹后神经痛的治疗．中国临床医生，2003，31：10-14.

[148]刘洁，邓列华，罗育武．老年带状疱疹94例临床分析．广东医学，2003，24：173-174.

[149]徐建国．慢性疼痛的药物治疗．临床麻醉学杂志，2003，19：298-301.

[150]谭宪湖．带状疱疹及带状疱疹后神经痛的治疗进展．国外医学：麻醉学与复苏分册，2003，4.

[151]史卫国．神经病理性疼痛治疗药物的治疗进展．国外医学：药学分册，2003，5.

[152]黄乔东，高崇荣．神经疼痛的病理机制与治疗进展．中华医学杂志，2003，23：2014-2016.

[153]刘卫，李玲．中枢性疼痛．中国临床康复，2002，6：1707-1709.

[154]赵晶，叶铁虎，罗爱伦．镇痛药物及其应用．中国临床康复，2002，6：2350-2352.

[155]何进，何跃，刘皋林．抗惊厥药在神经性疼痛综合征治疗中的作用．中国临床药学杂志，2002，11：380-383.